Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Overview
This bill requires New Jersey FamilyCare to reimburse inpatient providers at the same rate as outpatient providers for long-acting injectable antipsychotic drugs. Currently, inpatient reimbursement is based on Diagnostic Related Groups (DRGs), which may not fully account for the cost of these medications. The goal is to ensure that inpatient providers are fairly compensated for administering these drugs, leading to better medication adherence and patient outcomes. The bill also clarifies rules for pharmacist administration of these medications.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Introduced
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
4 on record
Primary sponsors
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours